OCULAR THERAPEUTIX™ ANNOUNCES TOPLINE PHASE 1 CLINICAL TRIAL RESULTS OF OTX-CSI

100820_Ocular_Therapeutixâ¢_Announces_T

.

Download • 77KB

Industry News

Recent Posts

See All

Symvivo Corporation Announces Research Collaboration With Janssen

Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has entered into a research collaboration with Janssen Biote

JADAK announces integrated secure access module for iClass and Prox encrypted badge reading in medic

Jadak, a business unit of Novanta Corporation (“Novanta”), announces the release of the ThingMagic M3e LF/HF RFID Secure Module enabled with theability to read iClass and Prox encrypted badges in medi

Bayer Completes Acquisition of the UK-based Biotech Company KaNDy Therapeutics Ltd

"Bayer completed the acquisition of UK-based biotech company KaNDy Therapeutics Ltd. to expand its drug development pipeline in women’s healthcare."